MEK inhibitors in non-V600 BRAF mutations and fusions

por Johnson, Douglas B., Nebhan, Caroline A., Noel, Marcus S.
Publicado 2020

Impact of Patient Age on Clinical Efficacy and Toxicity of Checkpoint Inhibitor Therapy

por Wong, Selina K., Nebhan, Caroline A., Johnson, Douglas B.
Publicado 2021

Immune-checkpoint inhibitors: long-term implications of toxicity

por Johnson, Douglas B., Nebhan, Caroline A., Moslehi, Javid J., Balko, Justin M.
Publicado 2022

Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology

por Choucair, Khalil, Naqash, Abdul Rafeh, Nebhan, Caroline A, Nipp, Ryan, Johnson, Douglas B, Saeed, Anwaar
Publicado 2022

Evaluation of healthcare-associated infection rates in patients with hematologic malignancies and stem cell transplantation during the coronavirus disease 2019 (COVID-19) pandemic

por Bobbitt, Laura J., Satyanarayana, Gowri, Van Metre Baum, Laura, Nebhan, Caroline A., Kassim, Adetola A., Gatwood, Katie S.
Publicado 2022

Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin

por Fahey, Catherine C., Nebhan, Caroline A., York, Sally, Davis, Nancy B., Hurley, Paula J., Gordetsky, Jennifer B., Schaffer, Kerry R.
Publicado 2023

Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients

por Yan, Chi, Chen, Sheau-Chiann, Ayers, Gregory D., Nebhan, Caroline A., Roland, Joseph T., Weiss, Vivian L., Johnson, Douglas B., Richmond, Ann
Publicado 2022

Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma

por Yan, Chi, Nebhan, Caroline A., Saleh, Nabil, Shattuck-Brandt, Rebecca, Chen, Sheau-Chiann, Ayers, Gregory D., Weiss, Vivian, Richmond, Ann, Vilgelm, Anna E.
Publicado 2023

Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade

por Yan, Chi, Saleh, Nabil, Yang, Jinming, Nebhan, Caroline A., Vilgelm, Anna E., Reddy, E. Premkumar, Roland, Joseph T., Johnson, Douglas B., Chen, Sheau-Chiann, Shattuck-Brandt, Rebecca L., Ayers, Gregory D., Richmond, Ann
Publicado 2021

Clinical Activity of Mitogen-Activated Protein Kinase–Targeted Therapies in Patients With Non–V600 BRAF-Mutant Tumors

por Dankner, Matthew, Wang, Yifan, Fazelzad, Rouhi, Johnson, Benny, Nebhan, Caroline A., Dagogo-Jack, Ibiayi, Myall, Nathaniel J., Richtig, Georg, Bracht, Jillian W.P., Gerlinger, Marco, Shinozaki, Eiji, Yoshino, Takayuki, Kotani, Daisuke, Fangusaro, Jason R., Gautschi, Oliver, Mazieres, Julien, Sosman, Jeffrey A., Kopetz, Scott, Subbiah, Vivek, Davies, Michael A., Groover, Anna L., Sullivan, Ryan J., Flaherty, Keith T., Johnson, Douglas B., Benedetti, Andrea, Cescon, David W., Spreafico, Anna, Zogopoulos, George, Rose, April A.N.
Publicado 2022